Securities and Finance

Financial Asset and Business Valuation

Financial Asset and Business Valuation

NERA economists help clients establish a fair and accurate valuation of a business or financial asset. Business valuation depends on financial forecasting and analysis -- but that is only the beginning. To make sound forecasts, it is important to understand the dynamics of the marketplace. This is the hallmark of NERA's approach -- one that has been successfully used by business owners and attorneys in litigation, and investment bankers/venture capitalists interested in acquiring a real measure of business value.  Similarly, financial asset valuation requires going beyond just plugging numbers into an equation, but also recognizing whether a standard financial model is appropriate for the financial asset being valued.

Name Title Location Phone Email
Lucy P. Allen Senior Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Bradley A. Heys Senior Managing Director Toronto
New York City
+1 416 868 7312
+1 212 345 3000
brad.heys@nera.com
Dr. Vinita Juneja Senior Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice
New York City
London
Toronto
+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314
vinita.juneja@nera.com
Dr. Denise Neumann Martin Senior Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. Faten Sabry Senior Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Dr. David Tabak Senior Managing Director New York City +1 212 345 2176 david.tabak@nera.com
Adam Warren Senior Managing Director Chicago +1 (312) 573-2821 adam.warren@nera.com
Dr. Ling Ling Ang Managing Director Washington, DC
Chicago
+1 202 466 9259
+312 573 2827
lingling.ang@nera.com
Dr. Jordan Milev Managing Director New York City +1 212 345 5516 jordan.milev@nera.com
Dr. Airat Chanyshev Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Dr. Alan Grant Director Washington, DC +1 202 466 3510 alan.grant@nera.com
Timothy McKenna Director Los Angeles
New York City
+1 213 346 3041
+1 212 345 3000
timothy.mckenna@nera.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London
+1 416 868 7311
+1 917 475 0020
+44 20 3769 1096
mark.berenblut.affiliate@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London
+1 212 345 5407
+44 20 7659 8500
andrew.carron.affiliate@nera.com
Dr. Alan Cox Affiliated Consultant San Francisco +1 415 291 1000 alan.cox.affiliate@nera.com
Dr. James Overdahl Affiliated Industry Expert Washington, DC +1 202 547 3035 joverdahl@deltastrat.com
Dr. Michael Rosenzweig Affiliated Consultant Washington, DC +1 202 466 9231 michael.rosenzweig.affiliate@nera.com
Title Type Author
Recent Trends in Securities Class Action Litigation: H1 2023 Update Report Edward Flores and Svetlana Starykh
Trends in Canadian Securities Class Actions: 2021 Update White Paper Bradley A. Heys, Robert Patton, Jielei Mao
Class Action Lawsuits: Opportunities to Apply Econometrics and Statistics Published Article Dr. Ling Ling Ang, Dr. Jordan Milev, and Dr. John Scalf
Fintech Developments and Antitrust Considerations in Payments Published Article Dr. Ling Ling Ang and Dr. Will Taylor
The Role of Punitive Damages in Asbestos Litigation Published Article Faten Sabry and Sungi Lee, et al.
Recent Trends in Securities Class Action Litigation Janeen McIntosh and Svetlana Starykh
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Recent Trends in Securities Class Action Litigation: 2020 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
Recent Trends in Securities Class Action Litigation: H1 2020 Update Report Janeen McIntosh and Svetlana Starykh
How COVID-19 Impact Analysis May Shape MAE Disputes Published Article Dr. David Tabak and Edward Flores